Skip to main content

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

Feedback
Newsletter
RSS
Twitter

User Top Menu

Welcome, guest
Log In
Join
Why Join?

Search form

Search

About Us
- Overview
- Who We Are
- Contact
- Fan Mail
- How to Cite
News & Future Directions
Papers
Forums
- Discussions
- Webinars
Professional Resources
Research Resources
Click Here to Support MSDF

You are here

Most Viewed

Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
Mycophenolate mofetil in multiple sclerosis.
ECTRIMS 2013 Day 1
Keystone Symposia Conference: Autoimmunity and Tolerance
MS Patient, Ph.D.: Hoping New Biomarkers Make MS More Predictable
'Strikingly' Lower Familial Risk of MS Seen
Episode 69 with Dr. Alessandra Solari on information and decision tools for newly diagnosed patients
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
Precision medicine in chronic disease management: The MS BioScreen.
ECTRIMS 2013 Day 4
Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.
Nominations Open for Dystel Prize for MS Research
Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse.
Teriflunomide Gets High Marks in Yet Another Phase 3 Trial
5th Axon Degeneration Meeting
Biogen Idec and Genentech Announce Restructuring of anti-CD20 Collaboration Agreement
CellCept Drug Details
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group.
Unusual association of Arnold-Chiari malformation and vitamin B12 deficiency.
Episode 68 with Dr. Philip De Jager on the state of MS genetics
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Phase II Study with Ocrelizumab Shows Significant Reduction in Disease Activity for Multiple Sclerosis Patients
Episode 64 with Dr. Helen Tremlett on pediatric MS and the gut microbiome
Safety study of BIIB033 in subjects with multiple sclerosis

Pages

« first
‹ previous
…
39
40
41
42
43
44
45
46
47
…
next ›
last »

MSDF Footer

Copyright © 2014 MGH and ACP

Privacy
Terms of Use
How to Cite
FAQ/Help
Site Map
Support Us
Feedback
Image Credits

All site content, except where otherwise noted, is licensed under a Creative Commons BY license. Please let us know where and how you use MSDF material.

Content By

Software By